Related Experiment Video
Updated: Nov 25, 2025
08:31
Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
Published on: October 11, 2019
10.7K
[Chloroquine for COVID-19: a hype or not?]
J D Machiels1, M Ter Avest2, J Ten Oever3
1Radboudumc, afd. Medische Microbiologie,Nijmegen.
Nederlands Tijdschrift Voor Geneeskunde
|December 17, 2020
Summary
Chloroquine and hydroxychloroquine were hyped as COVID-19 cures but lacked evidence. Rigorous studies later confirmed these drugs were ineffective for treating COVID-19, leading to non-recommendation.
Area of Science:
- Pharmacology
- Infectious Diseases
- Public Health
Background:
- Social media and media coverage fueled a hype around chloroquine and hydroxychloroquine as potential COVID-19 treatments.
- Early studies lacked methodological rigor and peer review, contributing to misinformation.
- Public demand for effective COVID-19 therapies was high during the pandemic.
Purpose of the Study:
- To critically evaluate the evidence surrounding the use of chloroquine and hydroxychloroquine for COVID-19.
- To assess whether the widespread promotion of these drugs was justified by scientific data.
Main Methods:
- Review of early European studies on chloroquine/hydroxychloroquine for COVID-19.
- Analysis of the methodological quality and peer-review status of initial publications.
- Comparison with subsequent, better-designed studies.
Main Results:
- The initial European study had significant methodological flaws and was published prematurely.
- Later, well-designed studies demonstrated that chloroquine and hydroxychloroquine are not effective for COVID-19.
- The use of these drugs for COVID-19 was subsequently de-recommended.
Conclusions:
- The promotion of chloroquine and hydroxychloroquine as a COVID-19 miracle cure was a hype.
- Physicians should await robust scientific evidence before adopting new treatments, especially during a pandemic.
